In vivo, neutralization of excessive IL-1β in cryopyrinopathies and in deficiency of interleukin-1 receptor antagonist (DIRA) results in decrease in IL-6 production [10-12]. Here, IL6 is linked to cryopyrin-associated periodic syndrome.